Global Infertility Drugs and Devices Market is Expected to Reach USD 4,776.4 Million in 2017: Transparency Market …

ALBANY, New York, October 2, 2012 /PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Infertility Drugs andDevices Market - Global IndustryAnalysis, Size, Share and Forecast,2010 - 2017", the overall infertility drugs and devices market was estimated at USD 3,553.5 million in 2010 and is expected to reach an estimated value of USD 4,776.4 million by 2017, growing at a CAGR of 4.3% from 2012 - 2017. The global infertility drugs market revenue for the year 2010 was estimated at USD 2,486.7 million and is expected to reach an estimated value of USD 3,352.7 million in 2017, growing at a CAGR of 4.3% from 2012 - 2017. The global infertility devices market revenue was estimated at USD 1,066.7 million in 2010 and is expected to reach an estimated value of USD 1,423.6 million by 2017, growing at a CAGR of 4.2% from 2012 - 2017.

Browse thefull reportathttp://www.transparencymarketresearch.com/infertility-drugs-devices-market.html

The key growth drivers for infertility drugs and devices market include rising number of infertile people, increasing worldwide obesity and rising disposable incomes of the consumers. Other driving factors include rising number of smokers, increasing stress and pollution, adoption of babies by homosexual couples and the availability of government support for infertility abatement procedures. The global female infertile population seeking medical care was estimated to be 67.5 million in 2010 and the number is estimated to increase to reach 72.3 million by 2017. The number of infertile females opting for artificial insemination though their spouse's sperm was estimated at 31.4 million in 2010.

The Europe infertility drugs and devices market was estimated at USD 802.8 million in 2010 and is expected to reach an estimated value of USD 952.3 million by 2017, growing at a CAGR of 2.4% from 2012 - 2017. The North America infertility drugs and devices market was estimated at USD 1,382.8 million in 2010 and is expected to reach an estimated value of USD 1,628.5 million by 2017, growing at a CAGR of 2.3% from 2012 - 2017.

The growth of the market is restrained by factors such as limited insurance cover, religious bans on artificial insemination procedures especially Islamic bans, risk of repeat procedures, traditional infertility treatments like the Chinese infertility treatments, ban on artificial reproduction procedures in European region and patent expiration of infertility drugs.

Related & Recently Published Reports by Transparency Market Research

Global Cardiovascular Devices Market

Global Stents Market

Global Ultrasound Market

Link:
Global Infertility Drugs and Devices Market is Expected to Reach USD 4,776.4 Million in 2017: Transparency Market ...